ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

The beneficial effects of empagliflozin-metformin combination on cardiovascular risk factors in type 2 diabetes mellitus patients.

Maryam Aghajani Bac et al.PubMed ↗Publisher ↗

No numbers read from the abstract.